The "chemoinvasion assay": a tool to study tumor and endothelial cell invasion of basement membranes

被引:70
作者
Albini, A [1 ]
Benelli, R [1 ]
Noonan, DM [1 ]
Brigati, C [1 ]
机构
[1] Ist Nazl Ric Canc, I-16132 Genoa, Italy
关键词
invasion; metastasis; angiogenesis; basement membrane; chemoinvasion;
D O I
10.1387/ijdb.041822aa
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Several genetic and epigenetic factors, both in the cell and in the host, contribute to the progression of tumors towards metastases. The escape of cancer cells from a primary, localized tumor to distant organs transforms a relatively curable pathology to an almost untreatable one. Metastatic lesions are often resistant to cancer therapy because of the progressive phenotypic changes that they have undergone. In this article we will give a bird's eye view on the features of metastatic cells and potential therapeutic targets. In particular, the invasion of basement membranes represents a fundamental step for cell dispersion. Over seventeen years ago we established the Matrigel "chemoinvasion" assay, a useful tool for studying the mechanisms involved in tumor and endothelial cell invasion of basement membranes and for the screening of anti-invasive agents. We will describe the assay and review some of the major results it enabled to obtain.
引用
收藏
页码:563 / 571
页数:9
相关论文
共 70 条
[11]  
Chao C, 1996, CANCER RES, V56, P4811
[12]   Regulation of VEGF/VPF expression in tumor cells: Consequences for tumor growth and metastasis [J].
Claffey, KP ;
Robinson, GS .
CANCER AND METASTASIS REVIEWS, 1996, 15 (02) :165-176
[13]   Angiogenesis and the role of epigenetics in metastasis [J].
Coomber, BL ;
Yu, JL ;
Fathers, KE ;
Plumb, C ;
Rak, JW .
CLINICAL & EXPERIMENTAL METASTASIS, 2003, 20 (03) :215-227
[14]   Inflammation and cancer [J].
Coussens, LM ;
Werb, Z .
NATURE, 2002, 420 (6917) :860-867
[15]   MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis [J].
Coussens, LM ;
Tinkle, CL ;
Hanahan, D ;
Werb, Z .
CELL, 2000, 103 (03) :481-490
[16]   Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins αvβ3 and αvβ5 in patients with advanced solid tumours [J].
Eskens, FALM ;
Dumez, H ;
Hoekstra, R ;
Perschl, A ;
Brindley, C ;
Böttcher, S ;
Wynendaele, W ;
Drevs, J ;
Verweij, J ;
van Oosterom, AT .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (07) :917-926
[17]   Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines.: A process repressed through RAS/MAP kinase signaling pathways [J].
Esparza, J ;
Vilardell, C ;
Calvo, J ;
Juan, M ;
Vives, J ;
Urbano-Márquez, A ;
Yagüe, J ;
Cid, MC .
BLOOD, 1999, 94 (08) :2754-2766
[18]   Tissue inhibitors of metalloproteases: Regulation and biological activities [J].
Fassina, G ;
Ferrari, N ;
Brigati, C ;
Benelli, R ;
Santi, L ;
Noonan, DM ;
Albini, A .
CLINICAL & EXPERIMENTAL METASTASIS, 2000, 18 (02) :111-120
[19]   The biology of VEGF and its receptors [J].
Ferrara, N ;
Gerber, HP ;
LeCouter, J .
NATURE MEDICINE, 2003, 9 (06) :669-676
[20]   Critical determinants of metastasis [J].
Fidler, IJ .
SEMINARS IN CANCER BIOLOGY, 2002, 12 (02) :89-96